Compare Illumina, Inc. (ILMN) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs State Street Technology Select Sector SPDR ETF — how do they compare? Illumina, Inc. trades at $192.36 (market cap $27.94B), while State Street Technology Select Sector SPDR ETF trades at $180.4. The key difference: Illumina, Inc. is trading nearer its 52-week high, State Street Technology Select Sector SPDR ETF nearer its low. Which is the better fit depends on your goals.
| ILMN | XLK | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $194.33 | $198.21 |
52-Week Low | $91.00 | $127.49 |
Enterprise Value | $29.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $192.53, up 3.15% today, with bullish technical signals and strong fundamental recovery. The stock shows robust profitability with a 19.42% net margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and new executive appointments, reinforcing growth prospects in genomics.
Outlook remains positive driven by sequencing demand and cost control, but risks include competitive pressure from Roche's new sequencer and China market weakness. Analyst consensus is Buy with a $178 target, though the current price exceeds this, suggesting cautious optimism amid execution risks.
XLK, the Technology Select Sector SPDR Fund, trades at $175.71 with a slight 0.07% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators are neutral. The fund has delivered strong year-to-date performance, up 33% as of July 2, 2026 (ETF Trends), but faces concentration risks in mega-cap tech holdings. Recent news highlights ongoing institutional interest in tech ETFs amid robust earnings expectations for the sector.
The outlook for XLK remains tied to technology sector strength, with Q2 earnings expected to show 23.3% growth for the S&P 500 (ETF Trends, July 13, 2026). Key risks include sector concentration and market volatility. Wall Street sentiment is positive due to strong fundamentals, but investors should monitor earnings results and Fed policy impacts on growth stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
